NanoViricides
NNVC
39 hedge funds and large institutions have $1.23M invested in NanoViricides in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
95% more capital invested
Capital invested by funds: $630K → $1.23M (+$596K)
0.07% more ownership
Funds ownership: 0.25% → 0.33% (+0.07%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
3% less funds holding
Funds holding: 40 → 39 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$445K |
| 2 |
Renaissance Technologies
New York
|
+$28.4K |
| 3 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$15.4K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$9.18K |
| 5 |
HIMC
Heritage Investors Management Corp
Bethesda,
Maryland
|
+$5.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$14K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$13K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5K |
| 4 |
VF
Virtu Financial
New York
|
-$5K |
| 5 |
Millennium Management
New York
|
-$3K |
NNVC Hedge Fund Activity: Q1 2019 in Review
39 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2019, worth a combined $1.23M — up 95% from $630K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of NNVC and 6 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $445K. The largest seller was Citadel Advisors, exiting entirely with an estimated $14K sold.
- 39 institutional investors held NanoViricides (NNVC) as of Q1 2019, down from 40 in Q4 2018.
- Funds reported $1.23M of NanoViricides stock for Q1 2019, up 95% quarter-over-quarter.
- 6 funds opened new NanoViricides positions in Q1 2019 and 7 closed out, a net change of -1 holder.
- The largest NanoViricides buyer in Q1 2019 was Hudson Bay Capital Management, an estimated $445K added.
- The largest NanoViricides seller in Q1 2019 was Citadel Advisors, an estimated $14K sold.
Based on aggregated 13F filings for Q1 2019.